Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug;18(8):409-410.
doi: 10.1038/s41579-020-0395-y.

Antimicrobial use, drug-resistant infections and COVID-19

Timothy M Rawson  1 , Damien Ming  1 , Raheelah Ahmad  1 , Luke S P Moore  1 , Alison H Holmes  2
Affiliations

Antimicrobial use, drug-resistant infections and COVID-19

Timothy M Rawson et al. Nat Rev Microbiol. 2020 Aug.

Abstract

Coronavirus disease 2019 may have a complex long-term impact on antimicrobial resistance (AMR). Coordinated strategies at the individual, health-care and policy levels are urgently required to inform necessary actions to reduce the potential longer-term impact on AMR and on access to effective antimicrobials.

PubMed Disclaimer

Conflict of interest statement

L.S.P.M. has consulted for DNAelectronics (2015–2018), Dairy Crest (2017–2018), Umovis Lab (2020) and Pfizer (2018–2020), received speaker fees from Profile Pharma (2018), received research grants from CW + Charity (2018–2019) and Leo Pharma (2016), and educational support from Eumedica (2016–2018). The other authors declare no competing interests.

References

    1. Rawson TM, et al. COVID-19 and the potential long term impact on antimicrobial resistance. J. Antimicrob. Chemother. 2020 doi: 10.1093/jac/dkaa194. - DOI - PMC - PubMed
    1. Gautret P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int. J. Antimicrob. Agents. 2020 doi: 10.1016/j.ijantimicag.2020.105949. - DOI - PMC - PubMed
    1. Cao B, et al. A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. N. Engl. J. Med. 2020;382:1787–1799. doi: 10.1056/NEJMoa2001282. - DOI - PMC - PubMed
    1. Rawson TM, et al. Bacterial and fungal co-infection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin. Infect. Dis. 2020 doi: 10.1093/cid/ciaa530. - DOI - PMC - PubMed
    1. Hollander JE, Carr BG. Virtually perfect? Telemedicine for Covid-19. N. Engl. J. Med. 2020;382:1679–1681. doi: 10.1056/NEJMp2003539. - DOI - PubMed

Publication types

MeSH terms

Substances